Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Revelation Pharma Strengthens Its Nationwide Presence in ENT and Animal Health with Acquisition of Cascade Specialty Pharmacy
-
Similarweb’s 2025 Digital 100 Celebrates Web and App Growth in the US, UK, France, Germany, Japan, Australia, India, and Brazil
-
FTAI BREAKING UPDATE: FTAI Aviation Ltd. Investors are Notified of Audit Committee Investigation and Potential Delay in Earnings
-
SYM DEADLINE NOTIFICATION: BFA Law Reminds Symbotic Inc. Investors to Contact the Firm before February 3 Class Action Deadline
-
NXT DEADLINE NOTIFICATION: BFA Law Reminds Nextracker Inc. Investors to Contact the Firm before February 25 Class Action Deadline
-
MQ DEADLINE NOTIFICATION: BFA Law Reminds Marqeta, Inc. Investors to Contact the Firm before February 7 Class Action Deadline
-
CPRI DEADLINE NOTIFICATION: BFA Law Reminds Capri Holdings Limited Investors to Contact the Firm before February 21 Class Action Deadline
-
BIOA DEADLINE NOTIFICATION: BFA Law Reminds BioAge Labs Investors to Contact the Firm before March 10 Class Action Deadline
-
APLT DEADLINE NOTIFICATION: BFA Law Reminds Applied Therapeutics, Inc. Investors to Contact the Firm before February 18 Class Action Deadline
-
Say Goodbye to Boring Interiors - Hernest's Latest Designs Are Here to Dazzle
-
AvaWatz Combines AI Innovation with Everyday Safety in New Investment Opportunity
-
Nebius AI Studio Introduces One of the Most Cost-Effective Suite for Text-to-image Generation With Leading Open-Source AI Models
-
Q4 Appoints Jake Wolff as Chief Revenue Officer
-
Equativ Unveils Maestro by Equativ: Its Most Advanced End-to-End Curation Platform for Enhanced Campaign Performance and Greater Control for Advertisers
-
GlobeTopper Achieves $39.5M in 2024 Revenue, Driven by Strong Q4 Performance
-
Artax Biopharma achieves clinical validation of first-in-class, oral, Nck modulator AX-158 for autoimmune disease in phase 2a study
-
Persistent Delivers Strong Q3 FY25 Performance with $360.2M Revenue, 4.3% Q-o-Q, 19.9% Y-o-Y Growth
-
REI Systems Secures Position on Navy SeaPort Next Generation (NxG) Contract Vehicle
-
Encore Multifamily Secures $48.7 Million HUD Loan for Fort Myers Development
-
Barksdale Resources Corp. Intersects High-Grade Sulfide "Exhaust" from a Larger "Engine"
-
City of Taunton joins the Massachusetts Purchasing Group
-
Oncolytics Biotech(R) to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
-
Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
-
IFI Releases New Training Video Library to Fight Financial Crime
-
Ameresco Partners with North Ayrshire Council to Advance Net-Zero Goals with Solar Farms on Repurposed Landfill Sites
-
Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
-
pharosIQ Enhances Advanced AI Technology, Setting New Standards in Precision Intent-Driven B2B Targeting
-
Red Light Holland Appoints Keith Li as Chief Financial Officer and Provides Corporate Updates
-
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
-
PureCars Introduces RylieAI: The Leading Edge of Automotive Advertising Technology
-
Care Access Makes No-Cost Heart & Kidney Health Screenings Available in Winter Park, Including Testing for Dangerous Cholesterol Type Lp(a)
-
IoT Breakthrough Names SmartBear API Hub as 2025 Enterprise Solution of the Year
-
Lorica Appoints Marcella Arthur as CEO to Drive Innovation in Privacy-Enhancing AI
-
ImagineAR Introducing 'AI/AR-as-a-Service' Platform, Transforming Immersive Customer Experiences
-
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
-
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
-
The Now Corporation (OTC:NWPN) Subsidiary, Green Rain Solar Inc., Explores Selling Development Rights for Solar Farm Project in Greece, NY
-
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating TransMedics Group, Ltd. for potential violations of securities laws
-
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldcliff Extends Strike of High Grade Silver at Ainsworth
-
United States Antimony Corporation Provides Operational Update on Madero, Mexico Smelter
-
ZM TRUCKS ANNOUNCES FIRST NORTH AMERICAN MANUFACTURING PLANT AND NEW REGIONAL HEADQUARTERS IN FONTANA, CALIFORNIA
-
Magna Terra Announces $450,000 Premium Flow-Through Private Placement
-
Sonim Technologies Announces Inbound Strategic Interest, Forms Special Committee and Engages Roth Capital Partners to Evaluate Strategic Alternatives
-
Berkeley SkyDeck and UC Berkeley Partner with Mayfield to Support AI-Focused Student Entrepreneurs
-
App Orchid Sets New Benchmark for Text-to-SQL Accuracy with Ontology-Driven AI Solution
-
Ridgeline Minerals Announces Non-Brokered Private Placement
-
Perisson Provides Updates on Its Colombia Asset Sale and CTO Status
-
Element 29 Announces Results from Elida Phase-III Drill Program including 1039.6 metres of 0.54% CuEq2
-
Form 8.3 - Warpaint London Plc
